Core Viewpoint - Analysts forecast that Uber Technologies (UBER) will report quarterly earnings of $0.79 per share, reflecting a year-over-year decline of 75.4%, while revenues are expected to reach $14.28 billion, an increase of 19.4% compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 4.9% over the past 30 days, indicating a collective reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and are strongly linked to short-term stock price performance [3]. Revenue Estimates - Analysts estimate 'Revenue- Mobility' will reach $8.27 billion, a year-over-year increase of 19.6% [5]. - 'Revenue- Freight' is projected at $1.28 billion, indicating a slight increase of 0.2% year-over-year [5]. - 'Revenue- Delivery' is expected to be $4.72 billion, reflecting a 25% increase compared to the previous year [5]. Geographic Revenue Breakdown - 'Geographic Revenue- Latin America' is estimated at $883.37 million, a 21.5% increase year-over-year [6]. - 'Geographic Revenue- United States and Canada' is projected to be $7.21 billion, showing a 14.2% increase [6]. - 'Geographic Revenue- Europe, Middle East and Africa' is expected to reach $4.23 billion, a 17.9% increase [7]. - 'Geographic Revenue- Asia Pacific' is estimated at $1.58 billion, reflecting an 18.7% increase [7]. Key Metrics - Analysts predict 'Gross Bookings - Total' will be $53.08 billion, compared to $44.20 billion in the previous year [7]. - 'Monthly Active Platform Consumers (MAPCs)' are expected to reach 198, up from 171 year-over-year [8]. - 'Trips' are projected to total 3,704, an increase from 3,068 in the same quarter last year [8]. - 'Gross Bookings - Delivery' is estimated at $24.76 billion, compared to $20.13 billion in the previous year [8]. - 'Gross Bookings - Mobility' is expected to reach $27.07 billion, up from $22.80 billion in the same quarter last year [9]. Market Performance - Uber shares have remained unchanged over the past month, while the Zacks S&P 500 composite has increased by 0.9% [9].

Core Viewpoint - Gentex (GNTX) reported quarterly earnings of $0.43 per share, matching the Zacks Consensus Estimate, and showing an increase from $0.39 per share a year ago [1]. Financial Performance - The company posted revenues of $644.4 million for the quarter ended December 2025, which was 1.32% below the Zacks Consensus Estimate and an increase from $541.64 million year-over-year [2]. - Over the last four quarters, Gentex has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2]. Stock Performance - Gentex shares have increased approximately 3.3% since the beginning of the year, outperforming the S&P 500's gain of 1.8% [3]. - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3]. Future Outlook - The current consensus EPS estimate for the upcoming quarter is $0.45, with expected revenues of $656.65 million, and for the current fiscal year, the estimate is $1.93 on $2.68 billion in revenues [7]. - The estimate revisions trend for Gentex was favorable ahead of the earnings release, resulting in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6]. Industry Context - The Automotive - Original Equipment industry, to which Gentex belongs, is currently ranked in the bottom 35% of over 250 Zacks industries, suggesting potential challenges ahead [8].

In its upcoming report, MetLife (MET) is predicted by Wall Street analysts to post quarterly earnings of $2.36 per share, reflecting an increase of 13.5% compared to the same period last year. Revenues are forecasted to be $25.57 billion, representing a year-over-year increase of 29.6%.The consensus EPS estimate for the quarter has undergone a downward revision of 0.7% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial ...

Core Viewpoint - RPC's shares have shown significant growth, driven by optimism in the oil and gas sector, with a notable increase in demand for oilfield services [2][3]. Group 1: Stock Performance - RPC shares ended the last trading session 5.5% higher at $6.7, with a 16.7% gain over the past four weeks [1]. - The stock experienced impressive trading volume, indicating strong investor interest [1]. Group 2: Market Conditions - Despite a moderation in oil prices, they remain at levels that are economically attractive for exploration and production companies, supporting sustained drilling and completion activity [2]. - The favorable activity backdrop is expected to lead to strong free cash flows for RPC throughout the year [2]. Group 3: Earnings Expectations - RPC is projected to report quarterly earnings of $0.07 per share, reflecting a year-over-year increase of 16.7%, with revenues expected to reach $425 million, up 26.7% from the previous year [3]. - The consensus EPS estimate for RPC has remained unchanged over the last 30 days, indicating stability in earnings expectations [4]. Group 4: Industry Context - RPC is part of the Zacks Oil and Gas - Field Services industry, which includes other companies like Subsea 7 SA, which has also seen positive stock performance [5]. - Subsea 7's EPS estimate has remained unchanged, with a significant year-over-year increase of 742.9%, highlighting strong performance within the industry [6].

分组1 - American Express reported quarterly earnings of $3.53 per share, slightly missing the Zacks Consensus Estimate of $3.54 per share, but showing an increase from $3.04 per share a year ago, resulting in an earnings surprise of -0.28% [1] - The company posted revenues of $18.98 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.84% and increasing from $17.18 billion year-over-year [2] - Over the last four quarters, American Express has exceeded consensus EPS estimates three times and has also topped consensus revenue estimates three times [2] 分组2 - The stock has underperformed the market, losing about 3.1% since the beginning of the year, while the S&P 500 has gained 1.8% [3] - The current consensus EPS estimate for the upcoming quarter is $3.95 on revenues of $18.44 billion, and for the current fiscal year, it is $17.50 on revenues of $78.16 billion [7] - The Zacks Industry Rank for Financial - Miscellaneous Services is currently in the top 39% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]

Company Overview - Southern Copper (SCCO) shares increased by 4.9% to $207.93 in the last trading session, with a notable trading volume, contributing to a 38.1% gain over the past four weeks [1] - The stock's rise is attributed to a significant increase in copper prices, which have risen by 40.8% over the past year, currently trading near a record high of $6 per pound due to tightening supply concerns [1] Earnings Expectations - Southern Copper is projected to report quarterly earnings of $1.46 per share, reflecting a year-over-year increase of 44.6%, with revenues expected to reach $3.62 billion, a 30% increase from the same quarter last year [2] - Despite positive earnings and revenue growth expectations, a recent revision of the consensus EPS estimate has been lowered by 1.3% over the last 30 days, indicating a potential negative trend in earnings estimate revisions [3] Industry Context - Southern Copper operates within the Zacks Mining - Non Ferrous industry, where another company, Coeur Mining (CDE), experienced a 4.1% decline in its stock price, closing at $24.57, despite a 43.7% return over the past month [3] - Coeur Mining's consensus EPS estimate has decreased by 15.9% over the past month to $0.33, although this still represents a 200% increase compared to the previous year [4]

Company Overview - Regenxbio (RGNX) shares increased by 5.4% to close at $11.6, following a notable trading volume, despite a 23.5% loss over the past four weeks [1] - The stock's rebound is attributed to a market correction after a steep selloff due to the FDA's clinical hold on its gene therapy RGX-111 for MPS I and RGX-121 for MPS II, following a case of neoplasm in a patient [2] Financial Performance - Regenxbio is expected to report a quarterly loss of $0.99 per share, reflecting a year-over-year change of +2%, with revenues projected at $31.49 million, an increase of 48.5% from the previous year [3] - The consensus EPS estimate for the upcoming quarter has remained unchanged over the last 30 days, indicating a lack of upward trend in earnings estimate revisions [4] Industry Context - Regenxbio is part of the Zacks Medical - Biomedical and Genetics industry, where another company, CytomX Therapeutics (CTMX), experienced a 2.7% decline to $5.74, despite a 38.5% return over the past month [4] - CytomX Therapeutics' consensus EPS estimate has decreased by 0.5% to -$0.08, representing a significant year-over-year change of -136.4% [5]

Core Viewpoint - DXC Technology Company reported quarterly earnings of $0.96 per share, exceeding the Zacks Consensus Estimate of $0.85 per share, and showing an increase from $0.92 per share a year ago, representing an earnings surprise of +12.94% [1] Group 1: Earnings Performance - The company has surpassed consensus EPS estimates for the last four quarters [2] - DXC Technology's revenues for the quarter ended December 2025 were $3.19 billion, slightly missing the Zacks Consensus Estimate by 0.31%, and down from $3.23 billion year-over-year [2] - The company has topped consensus revenue estimates two times over the last four quarters [2] Group 2: Stock Performance and Outlook - DXC Technology shares have declined approximately 1.5% since the beginning of the year, while the S&P 500 has gained 1.9% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - A favorable trend in estimate revisions ahead of the earnings release has resulted in a Zacks Rank 2 (Buy) for the stock, indicating expected outperformance in the near future [6] Group 3: Future Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $0.78 on revenues of $3.2 billion, and for the current fiscal year, it is $3.16 on revenues of $12.72 billion [7] - The outlook for the Computers - IT Services industry, where DXC Technology operates, is currently in the top 39% of Zacks industries, suggesting a favorable environment for stock performance [8]

分组1 - Eastman Chemical reported quarterly earnings of $0.75 per share, missing the Zacks Consensus Estimate of $0.76 per share, and down from $1.87 per share a year ago, representing an earnings surprise of -1.68% [1] - The company posted revenues of $1.97 billion for the quarter, missing the Zacks Consensus Estimate by 3.15%, and down from $2.25 billion year-over-year [2] - Over the last four quarters, Eastman Chemical has surpassed consensus EPS estimates only once and has not beaten consensus revenue estimates [2] 分组2 - The stock has gained about 8.2% since the beginning of the year, outperforming the S&P 500's gain of 1.9% [3] - The current consensus EPS estimate for the coming quarter is $1.24 on revenues of $2.19 billion, and for the current fiscal year, it is $5.99 on revenues of $8.86 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 14% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

分组1 - Citizens Financial Services reported quarterly earnings of $2.18 per share, exceeding the Zacks Consensus Estimate of $2.07 per share, and up from $1.68 per share a year ago, representing an earnings surprise of +5.31% [1] - The company posted revenues of $29.61 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.71%, compared to year-ago revenues of $26.21 million [2] - Citizens Financial Services has outperformed the S&P 500, with shares increasing about 7.2% since the beginning of the year, while the S&P 500 gained 1.9% [3] 分组2 - The current consensus EPS estimate for the coming quarter is $1.96 on revenues of $29.1 million, and for the current fiscal year, it is $7.70 on revenues of $118.7 million [7] - The Zacks Industry Rank for Banks - Northeast is currently in the top 23% of over 250 Zacks industries, indicating a favorable outlook for the industry [8] - The estimate revisions trend for Citizens Financial Services was favorable ahead of the earnings release, resulting in a Zacks Rank 1 (Strong Buy) for the stock, suggesting expected outperformance in the near future [6]